287 related articles for article (PubMed ID: 9053836)
1. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.
Terradillos O; Billet O; Renard CA; Levy R; Molina T; Briand P; Buendia MA
Oncogene; 1997 Jan; 14(4):395-404. PubMed ID: 9053836
[TBL] [Abstract][Full Text] [Related]
2. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion.
Etiemble J; Degott C; Renard CA; Fourel G; Shamoon B; Vitvitski-Trépo L; Hsu TY; Tiollais P; Babinet C; Buendia MA
Oncogene; 1994 Mar; 9(3):727-37. PubMed ID: 8108115
[TBL] [Abstract][Full Text] [Related]
3. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
4. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
[TBL] [Abstract][Full Text] [Related]
5. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro.
Terradillos O; Pollicino T; Lecoeur H; Tripodi M; Gougeon ML; Tiollais P; Buendia MA
Oncogene; 1998 Oct; 17(16):2115-23. PubMed ID: 9798683
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA
Oncogene; 2000 May; 19(22):2678-86. PubMed ID: 10851067
[TBL] [Abstract][Full Text] [Related]
7. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA
Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580
[TBL] [Abstract][Full Text] [Related]
8. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
9. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by small interfering RNAs.
Hung L; Kumar V
FEBS Lett; 2004 Feb; 560(1-3):210-4. PubMed ID: 14988024
[TBL] [Abstract][Full Text] [Related]
11. Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks.
Bruni R; Conti I; Villano U; Giuseppetti R; Palmieri G; Rapicetta M
Virology; 2006 Feb; 345(1):258-69. PubMed ID: 16271377
[TBL] [Abstract][Full Text] [Related]
12. Activation of the N-myc2 oncogene by woodchuck hepatitis virus integration in the linked downstream b3n locus in woodchuck hepatocellular carcinoma.
Bruni R; D'Ugo E; Giuseppetti R; Argentini C; Rapicetta M
Virology; 1999 May; 257(2):483-90. PubMed ID: 10329558
[TBL] [Abstract][Full Text] [Related]
13. Antisense regulation of expression and transactivation functions of the tumorigenic HBx and c-myc genes.
Hung L; Kumar V
Biochem Biophys Res Commun; 2006 May; 344(1):293-9. PubMed ID: 16616001
[TBL] [Abstract][Full Text] [Related]
14. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.
Terradillos O; de La Coste A; Pollicino T; Neuveut C; Sitterlin D; Lecoeur H; Gougeon ML; Kahn A; Buendia MA
Oncogene; 2002 Jan; 21(3):377-86. PubMed ID: 11821950
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of interferon alpha in primary prevention of preneoplastic lesions in a transgenic murine model of hepatocellular carcinoma related to the interaction between woodchuck hepatitis viruses and c-myc oncogene].
Merle P; Levy R; Vitvitski L; Chevallier M; Buendia MA; Trepo C
Gastroenterol Clin Biol; 1997; 21(6-7):459-65. PubMed ID: 9295972
[TBL] [Abstract][Full Text] [Related]
16. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
17. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein and c-Myc cooperate in the upregulation of ribosome biogenesis and in cellular transformation.
Shukla SK; Kumar V
FEBS J; 2012 Oct; 279(20):3859-71. PubMed ID: 22889122
[TBL] [Abstract][Full Text] [Related]
19. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis B virus and hepatocellular carcinoma].
Tiollais P; Pineau P; Wei Y; Dejean A; Buendia MA
Bull Acad Natl Med; 1998; 182(1):73-7; discussion 77-8. PubMed ID: 9622933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
